Company

Viridian Therapeutics, Inc. VRDN

Tracked across 2 disclosed holders on Protégé.

Held by these investors

Investor% of portfolioValue
Baker Brothers Investments0.2%$43.8M
Eleva Capital0.0%$139K

Open the full company deep-dive →